Hosking DJ - Search Results

1

Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial.

Reid IR, Nicholson GC, Weinstein RS, Hosking DJ, Cundy T, Kotowicz MA, Murphy WA Jr, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ. Reid IR, et al. Among authors: hosking dj. Am J Med. 1996 Oct;101(4):341-8. doi: 10.1016/s0002-9343(96)00227-6. Am J Med. 1996. PMID: 8873503 Clinical Trial.

2

Bisphosphonates in Paget's disease.

Reid IR, Hosking DJ. Reid IR, et al. Among authors: hosking dj. Bone. 2011 Jul;49(1):89-94. doi: 10.1016/j.bone.2010.09.002. Epub 2010 Sep 9. Bone. 2011. PMID: 20832512 Review.

3

A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.

Reid IR, Lyles K, Su G, Brown JP, Walsh JP, del Pino-Montes J, Miller PD, Fraser WD, Cafoncelli S, Bucci-Rechtweg C, Hosking DJ. Reid IR, et al. Among authors: hosking dj. J Bone Miner Res. 2011 Sep;26(9):2261-70. doi: 10.1002/jbmr.438. J Bone Miner Res. 2011. PMID: 21638319 Free article.

4

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D. Reid IR, et al. N Engl J Med. 2005 Sep 1;353(9):898-908. doi: 10.1056/NEJMoa044241. N Engl J Med. 2005. PMID: 16135834 Free article. Clinical Trial.

5

Paget's disease of bone: an endocrine society clinical practice guideline.

Singer FR, Bone HG 3rd, Hosking DJ, Lyles KW, Murad MH, Reid IR, Siris ES; Endocrine Society. Singer FR, et al. Among authors: hosking dj. J Clin Endocrinol Metab. 2014 Dec;99(12):4408-22. doi: 10.1210/jc.2014-2910. J Clin Endocrinol Metab. 2014. PMID: 25406796

6

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis.

Devogelaer JP, Broll H, Correa-Rotter R, Cumming DC, De Deuxchaisnes CN, Geusens P, Hosking D, Jaeger P, Kaufman JM, Leite M, Leon J, Liberman U, Menkes CJ, Meunier PJ, Reid I, Rodriguez J, Romanowicz A, Seeman E, Vermeulen A, Hirsch LJ, Lombardi A, Plezia K, Santora AC, Yates AJ, Yuan W. Devogelaer JP, et al. Bone. 1996 Feb;18(2):141-50. doi: 10.1016/8756-3282(95)00436-x. Bone. 1996. PMID: 8833208 Clinical Trial.

7

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ. Hosking D, et al. N Engl J Med. 1998 Feb 19;338(8):485-92. doi: 10.1056/NEJM199802193380801. N Engl J Med. 1998. PMID: 9443925 Free article. Clinical Trial.

8

Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.

Ravn P, Hosking D, Thompson D, Cizza G, Wasnich RD, McClung M, Yates AJ, Bjarnason NH, Christiansen C. Ravn P, et al. J Clin Endocrinol Metab. 1999 Jul;84(7):2363-8. doi: 10.1210/jcem.84.7.5847. J Clin Endocrinol Metab. 1999. PMID: 10404804 Clinical Trial.

9

Alendronate in the treatment of postmenopausal osteoporosis.

Hosking DJ, Favus M, Yates AJ. Hosking DJ, et al. Int J Clin Pract Suppl. 1999 Apr;101:27-35. Int J Clin Pract Suppl. 1999. PMID: 12669738 Clinical Trial.

10

Zoledronate.

Reid IR, Green JR, Lyles KW, Reid DM, Trechsel U, Hosking DJ, Black DM, Cummings SR, Russell RGG, Eriksen EF. Reid IR, et al. Among authors: hosking dj. Bone. 2020 Aug;137:115390. doi: 10.1016/j.bone.2020.115390. Epub 2020 Apr 27. Bone. 2020. PMID: 32353565

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters